These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23296515)

  • 1. Mesoporous silica-calcium phosphate-tuberculin purified protein derivative composites as an effective adjuvant for cancer immunotherapy.
    Li X; Wang X; Sogo Y; Ohno T; Onuma K; Ito A
    Adv Healthc Mater; 2013 Jun; 2(6):863-71. PubMed ID: 23296515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-Tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs.
    Rim HP; Min KH; Lee HJ; Jeong SY; Lee SC
    Angew Chem Int Ed Engl; 2011 Sep; 50(38):8853-7. PubMed ID: 21826770
    [No Abstract]   [Full Text] [Related]  

  • 3. Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy.
    Wang X; Li X; Ito A; Sogo Y; Ohno T
    J Biomed Mater Res A; 2014 Apr; 102(4):967-74. PubMed ID: 23650285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
    Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
    Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomineralization inspired surface engineering of nanocarriers for pH-responsive, targeted drug delivery.
    Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X
    Biomaterials; 2013 Jan; 34(4):1364-71. PubMed ID: 23140999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy.
    Wang X; Li X; Ito A; Sogo Y; Ohno T
    Acta Biomater; 2013 Jul; 9(7):7480-9. PubMed ID: 23541601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy.
    Xuan M; Shao J; Dai L; He Q; Li J
    Adv Healthc Mater; 2015 Aug; 4(11):1645-52. PubMed ID: 25960053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.
    Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y
    ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and cytotoxicological characterization of tuberculin purified protein derivative (PPD) conjugated to single-walled carbon nanotubes.
    Zeinali M; Jammalan M; Ardestani SK; Mosaveri N
    Immunol Lett; 2009 Sep; 126(1-2):48-53. PubMed ID: 19664657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality.
    Huang P; Chen Y; Lin H; Yu L; Zhang L; Wang L; Zhu Y; Shi J
    Biomaterials; 2017 May; 125():23-37. PubMed ID: 28226244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Brucella abortus lipopolysaccharide as an adjuvant for tuberculin PPD.
    Jamalan M; Ardestani SK; Zeinali M; Mosaveri N; Mohammad Taheri M
    Biologicals; 2011 Jan; 39(1):23-8. PubMed ID: 20965746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells.
    Gary-Bobo M; Brevet D; Benkirane-Jessel N; Raehm L; Maillard P; Garcia M; Durand JO
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):256-60. PubMed ID: 22959805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
    Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
    Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice.
    Vyakarnam A; Lachmann PJ; Sikora K
    Immunology; 1981 Feb; 42(2):337-48. PubMed ID: 6161889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.
    Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J
    ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.
    Knežević NŽ; Lin VS
    Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic composite of calcium phosphate-based mesoporous silica as a novel bone drug delivery system.
    Prokopowicz M; Szewczyk A; Skwira A; Sądej R; Walker G
    Drug Deliv Transl Res; 2020 Apr; 10(2):455-470. PubMed ID: 31820299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly monodisperse rattle-structured nanomaterials with gold nanorod core-mesoporous silica shell as drug delivery vehicles and nanoreactors.
    Choi E; Kwak M; Jang B; Piao Y
    Nanoscale; 2013 Jan; 5(1):151-4. PubMed ID: 23154837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
    Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymerised autologous tumor tissue particles in experimental cancer immunotherapy with special reference to the effects on the immune system of the host.
    Syrjänen KJ; Soimakallio S
    Arch Geschwulstforsch; 1980; 50(8):724-34. PubMed ID: 6784699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.